longbridgelongbridge
  • Products
  • Fees
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Rallybio(RLYB.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

PR Newswire·Yesterday at 01:19
US
TMHC
-0.14%
US
SUNE
-7.02%
US
RLYB
+1.23%
PR Newswire·Yesterday at 01:19
US
TMHC
-0.14%
US
SUNE
-7.02%
US
RLYB
+1.23%

Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure

Tip Ranks·06/01/2026 21:40
US
LIXT
+2.77%
Tip Ranks·06/01/2026 21:40
US
LIXT
+2.77%

<![CDATA[Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio]]>

Pharmexec·06/01/2026 21:42
US
EWTX
+1.29%
US
LLY
+0.57%
US
RLYB
+1.23%
Pharmexec·06/01/2026 21:42
US
EWTX
+1.29%
US
LLY
+0.57%
US
RLYB
+1.23%

Insider Buying: Rallybio (NASDAQ:RLYB) Major Shareholder Buys 10,200 Shares of Stock

Market Beat·05/21/2026 09:17
US
RLYB
+1.23%
US
FBT
+1.29%
US
BBH
0.00%
Market Beat·05/21/2026 09:17
US
RLYB
+1.23%
US
FBT
+1.29%
US
BBH
0.00%

Rallybio (NASDAQ:RLYB) Major Shareholder Adar1 Capital Management, Llc Acquires 800 Shares

Market Beat·05/14/2026 20:52
US
RLYB
+1.23%
Market Beat·05/14/2026 20:52
US
RLYB
+1.23%

Rallybio | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 212 K

Earnings Watch·05/14/2026 04:08
US
RLYB
+1.23%
Earnings Watch·05/14/2026 04:08
US
RLYB
+1.23%

Rallybio (RLYB) Projected to Post Quarterly Earnings on Tuesday

Market Beat·05/06/2026 01:07
US
RLYB
+1.23%
US
XBI
+1.22%
US
FBT
+1.29%
Market Beat·05/06/2026 01:07
US
RLYB
+1.23%
US
XBI
+1.22%
US
FBT
+1.29%
© 2026 Longbridge|Disclaimer

Event Tracking

May14
Rallybio released FY2026 Q1 earnings on May 13 (EST), actual revenue USD 212K (forecast USD 0), actual EPS USD -1.46 (forecast USD -1.2)
03:00
May4
Candid Therapeutics Terminates Merger Agreement with Rallybio and Signs New Agreement with UCB
11:55
Mar17
Rallybio released FY2025 earnings on March 16 (EST), actual revenue USD 858 K (forecast USD 733.33 K), actual EPS USD -1.5948 (forecast USD -3.0666)
03:00
Rallybio released FY2025 Q4 earnings on March 16 (EST), actual revenue USD 222K (forecast USD 133.33K), actual EPS USD -1.0297 (forecast USD -1.1733)
03:00
Nov7
Rallybio released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 212 K (forecast USD 66.67 K), actual EPS USD 2.8435 (forecast USD -1.7066)
04:00
Rallybio released FY2025 9 Months earnings on November 6, 2025 (EST), with actual revenue of USD 636 K and actual EPS of USD -0.5739
04:00

Schedules & Filings

Schedules
Filings
May13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 212 K, Net Income -8.278 M, EPS -1.46

Mar16
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 222 K, Net Income -5.852 M, EPS -1.0297

Feb6
Reverse Stock Split(EST)

1-for-8 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
DSY
16.010
+770.10%
+14.280
VSME
3.328
+304.15%
+2.468
CIIT
3.380
+181.66%
+2.170
CPOP
0.8909
+147.47%
+0.543
CHOW
0.6637
+89.95%
+0.316
HKIT
0.4544
+66.45%
+0.181
FLD
0.9800
+60.10%
+0.368
AMPGR
3.250
+56.25%
+1.170
WCT
1.970
+50.38%
+0.670
GLE
0.6602
+50.05%
+0.220
View More